Planned Trial: rhIL-15 & Mogamulizumab

by | May 3, 2022 | Clinical Trials

Planned trial:

  • Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for Patients with Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sézary Syndrome

Other guidelines and trials you may be interested in…